Skip to content
www.elpa.eu
MENU
MENU
HOME
ABOUT US
Our Mission
ANNUAL REPORTS
Statutes
Our team
Internal rules
FINANCES
Governance
Best practice
Codes of conduct
Finance and transparency
SUPPORTS AND GRANTS
Resource library
European social charter
QUARTAL NEWS REPORT
ELPA supporters, collaboration and partnership
Statutory Audit
Endorsement documents
ISO Certificate
MEMBERS
ELPA MEMBERS
BECOME A MEMBER
BECOME A SUPPORTER
ELPA Working Groups
PROJECTS
Hep-CORE Study
ELPA UNIVERSITY
Hep C – From Hell to Hope
ELPA INTERVIEWS
ELPA@HOME
Spring European HEPATIS-HIV Testing Week
Spring European Testing Week
Time To DeLiver
RESEARCH
EIT LIVERSCREEN
Liverhope
MICROB-PREDICT
IP cure B
DECISION
Galaxy
COBALT Study
LIVER DISEASES
ELPA Working Groups
Hepatic encephalopathy (HE)
Hepatitis B (HBV)
Hepatitis C (HCV)
Hepatocellular carcinoma (HCC)
Nonalcoholic steatohepatitis (NASH)
White Paper – Liver Cancer: No patient left behind
Liver Cancer
EU Projects
Rare liver diseases
NEWS
MEMBERS
Elpa Members
Become a Supporter
Become a Member
Members Login